Diane-35

DRUG3 trials

Sponsors

Aijun Sun, Inonu University, Xiaojun Chen

Conditions

Atypical Endometrial HyperplasiaEndometrial NeoplasmsPCOSPolycystic Ovary SyndromeProgesterone Resistance

Phase 2

A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS

Start: 2016-10-01End: 2018-08-31Target: 315Updated: 2018-02-05

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

RecruitingNCT05316935

Xiaojun ChenAtypical Endometrial Hyperplasia, Endometrial Neoplasms, Progesterone Resistance

Start: 2022-07-13End: 2027-03-30Target: 80Updated: 2025-08-11

Unknown Phase

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

Inonu UniversityPolycystic Ovary Syndrome

Start: 2021-03-01End: 2023-06-30Target: 42Updated: 2022-05-19

Related Papers

Serum metabolomic profiling reveals potential biomarkers in assessing the management of women with polycystic ovary syndrome: a randomized controlled trial

Chinese Medical Journal2021-12-062 citations

Is There An Advantage of Using Dingkun Pill () alone or in Combination with Diane-35 for Management of Polycystic Ovary Syndrome? A Randomized Controlled Trial.

2020-09-115 citations

Insulin Resistance in Polycystic Ovary Syndrome Improved by Chinese Medicine Dingkun Pill (): A Randomized Controlled Clinical Trial.

2019-04-0111 citations